Copyright
©The Author(s) 2017.
World J Gastroenterol. May 7, 2017; 23(17): 3174-3183
Published online May 7, 2017. doi: 10.3748/wjg.v23.i17.3174
Published online May 7, 2017. doi: 10.3748/wjg.v23.i17.3174
Patients characteristics | Group 1 (n = 24) | Group 2 (n = 30) | P value |
Age (yr) | 64.7 (56.0-67.9) | 64.2 (60.0-67.6) | 0.889 |
Gender, % men | 75 | 77 | 0.887 |
Body mass index (kg/m2) | 27.6 (25.0-30.3) | 26.2 (25.0-29.1) | 0.623 |
Smoking, % current smokers | 20.8 | 10.7 | 0.313 |
Barrett’s esophagus length (cm) | |||
C (circular extension) | 2 (1-6) | 1 (0-3) | 0.099 |
M (maximal extension) | 5 (4-8) | 5 (3-7) | 0.278 |
- Citation: Baldaque-Silva F, Vieth M, Debel M, Håkanson B, Thorell A, Lunet N, Song H, Mascarenhas-Saraiva M, Pereira G, Lundell L, Marschall HU. Impact of gastroesophageal reflux control through tailored proton pump inhibition therapy or fundoplication in patients with Barrett’s esophagus. World J Gastroenterol 2017; 23(17): 3174-3183
- URL: https://www.wjgnet.com/1007-9327/full/v23/i17/3174.htm
- DOI: https://dx.doi.org/10.3748/wjg.v23.i17.3174